Gregory M. Lucas

8.5k total citations · 1 hit paper
149 papers, 6.1k citations indexed

About

Gregory M. Lucas is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Gregory M. Lucas has authored 149 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Infectious Diseases, 87 papers in Epidemiology and 37 papers in Emergency Medicine. Recurrent topics in Gregory M. Lucas's work include HIV/AIDS Research and Interventions (90 papers), HIV, Drug Use, Sexual Risk (75 papers) and HIV/AIDS drug development and treatment (53 papers). Gregory M. Lucas is often cited by papers focused on HIV/AIDS Research and Interventions (90 papers), HIV, Drug Use, Sexual Risk (75 papers) and HIV/AIDS drug development and treatment (53 papers). Gregory M. Lucas collaborates with scholars based in United States, India and Israel. Gregory M. Lucas's co-authors include Richard D. Moore, Richard E. Chaisson, Mohamed G. Atta, Kelly A. Gebo, Derek M. Fine, Laura W. Cheever, Shruti H. Mehta, Jeanne Keruly, Richard Moore and Aylur K. Srikrishnan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Gregory M. Lucas

144 papers receiving 6.0k citations

Hit Papers

Highly Active Antiretrovi... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory M. Lucas United States 41 4.5k 3.1k 1.6k 1.5k 630 149 6.1k
Phyllis C. Tien United States 51 3.5k 0.8× 2.3k 0.8× 1.9k 1.2× 4.2k 2.8× 349 0.6× 288 8.2k
Jeanne Keruly United States 41 4.0k 0.9× 3.1k 1.0× 1.8k 1.1× 1.2k 0.8× 327 0.5× 126 5.7k
Edgar T. Overton United States 44 2.5k 0.5× 1.9k 0.6× 1.5k 0.9× 2.5k 1.7× 292 0.5× 194 5.6k
Estebán Martínez Spain 47 5.0k 1.1× 2.4k 0.8× 3.1k 1.9× 3.6k 2.4× 475 0.8× 323 8.5k
Kate Buchacz United States 38 3.2k 0.7× 2.2k 0.7× 1.1k 0.7× 1.5k 1.0× 267 0.4× 130 4.6k
Amanda Mocroft United Kingdom 55 9.4k 2.1× 5.2k 1.7× 5.0k 3.1× 4.7k 3.1× 321 0.5× 250 13.2k
Mallory D. Witt United States 37 2.7k 0.6× 1.7k 0.5× 1.6k 1.0× 1.7k 1.2× 146 0.2× 138 4.8k
Sonia Napravnik United States 36 2.6k 0.6× 1.6k 0.5× 1.2k 0.7× 933 0.6× 289 0.5× 173 4.1k
Sundhiya Mandalia United Kingdom 42 2.9k 0.6× 1.6k 0.5× 1.6k 1.0× 851 0.6× 276 0.4× 157 5.7k
Hernando Knobel Spain 38 2.7k 0.6× 1.2k 0.4× 1.5k 0.9× 1.5k 1.0× 252 0.4× 183 5.1k

Countries citing papers authored by Gregory M. Lucas

Since Specialization
Citations

This map shows the geographic impact of Gregory M. Lucas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Lucas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Lucas more than expected).

Fields of papers citing papers by Gregory M. Lucas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Lucas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Lucas. The network helps show where Gregory M. Lucas may publish in the future.

Co-authorship network of co-authors of Gregory M. Lucas

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory M. Lucas. A scholar is included among the top collaborators of Gregory M. Lucas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory M. Lucas. Gregory M. Lucas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosecrans, Amanda, Robert S. Harris, Darrell J. Gaskin, et al.. (2024). An Analysis of Social Determinants of Health and Their Implications for Hepatitis C Virus Treatment in People Who Inject Drugs: The Case of Baltimore. Open Forum Infectious Diseases. 11(4). ofae107–ofae107. 3 indexed citations
2.
Iqbal, Hussain Syed, Mark G. Anderson, Allison M. McFall, et al.. (2024). Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional Study. Open Forum Infectious Diseases. 11(7). ofae350–ofae350.
3.
Srikrishnan, Aylur K., Allison M. McFall, M. Suresh Kumar, et al.. (2024). Expanding single-venue services to better engage young people who inject drugs: insights from India. Harm Reduction Journal. 21(1). 170–170.
4.
Falade‐Nwulia, Oluwaseun, Sharon M. Kelly, Ju Nyeong Park, et al.. (2023). Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes. International Journal of Drug Policy. 121. 104191–104191. 5 indexed citations
5.
Sabri, Bushra, Chakra Budhathoki, Allison M. McFall, et al.. (2023). Cumulative violence exposures among men who have sex with men living with HIV in India: Psychosocial correlates of HIV care continuum outcomes. PLoS ONE. 18(12). e0295225–e0295225. 1 indexed citations
6.
Sabri, Bushra, M. Claire Greene, Simo Du, et al.. (2021). Exploring multilevel determinants of co-occurring violence, HIV, mental health and substance use problems. Journal of Ethnic & Cultural Diversity in Social Work. 32(4). 210–222. 3 indexed citations
8.
Cook, Ryan, Caroline King, Paula J. Lum, et al.. (2021). Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease. Drug and Alcohol Dependence. 228. 109077–109077. 12 indexed citations
9.
Rosecrans, Amanda, Robert S. Harris, Brian W. Weir, et al.. (2021). Mobile low-threshold buprenorphine integrated with infectious disease services. Journal of Substance Abuse Treatment. 133. 108553–108553. 28 indexed citations
10.
Solomon, Sunil S., Sunil S. Solomon, Thomas C. Quinn, et al.. (2019). Integrating HCV testing with HIV programs improves hepatitis C outcomes in people who inject drugs: A cluster-randomized trial. Journal of Hepatology. 72(1). 67–74. 26 indexed citations
11.
Sabri, Bushra, Allison M. McFall, Sunil S. Solomon, et al.. (2017). Gender Differences in Factors Related to HIV Risk Behaviors among People Who Inject Drugs in North-East India. PLoS ONE. 12(1). e0169482–e0169482. 14 indexed citations
12.
Solomon, Sunil S., Allison M. McFall, Gregory M. Lucas, et al.. (2017). Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis. PLoS Medicine. 14(11). e1002460–e1002460. 30 indexed citations
13.
Solomon, Sunil S., Sunil S. Solomon, Gregory M. Lucas, et al.. (2012). Impact of generic antiretroviral therapy (ART) and free ART programs on time to initiation of ART at a tertiary HIV care center in Chennai, India. AIDS Care. 25(8). 931–936. 4 indexed citations
14.
Atta, Mohamed G., Michelle M. Estrella, Michael Kuperman, et al.. (2012). HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney International. 82(3). 338–343. 41 indexed citations
15.
Lucas, Gregory M., Amina Chaudhry, Jeffrey H. Hsu, et al.. (2010). Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program. Annals of Internal Medicine. 5 indexed citations
16.
Riedel, David J., Kelly A. Gebo, Richard D. Moore, & Gregory M. Lucas. (2008). A Ten-Year Analysis of the Incidence and Risk Factors for Acute Pancreatitis Requiring Hospitalization in an Urban HIV Clinical Cohort. AIDS Patient Care and STDs. 22(2). 113–121. 31 indexed citations
17.
Lucas, Gregory M., Bryan Lau, Mohamed G. Atta, et al.. (2008). Chronic Kidney Disease Incidence, and Progression to End‐Stage Renal Disease, in HIV‐Infected Individuals: A Tale of Two Races. The Journal of Infectious Diseases. 197(11). 1548–1557. 166 indexed citations
18.
Lucas, Gregory M., et al.. (2007). Adherence, Drug Use, and Treatment Failure in a Methadone-Clinic–Based Program of Directly Administered Antiretroviral Therapy. AIDS Patient Care and STDs. 21(8). 564–574. 37 indexed citations
19.
Fine, Derek M., Neha Garg, Mark Haas, et al.. (2007). Cocaine Use and Hypertensive Renal Changes in HIV-Infected Individuals. Clinical Journal of the American Society of Nephrology. 2(6). 1125–1130. 22 indexed citations
20.
Lucas, Gregory M., Charles Flexner, & Richard D. Moore. (2002). Directly Administered Antiretroviral Therapy in the Treatment of HIV Infection: Benefit or Burden?. AIDS Patient Care and STDs. 16(11). 527–535. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026